Buy Ketamine HCl 500mg/10mL Injection Online USA – Nuvex Meds

• Product Name: Ketamine Hydrochloride (HCl) Injection

• Concentration & Format: 500 mg / 10 mL (50 mg/mL), Multiple-Dose Vial

• Category: General Anesthetic / NMDA Receptor Antagonist

• Primary Form: Sterile Liquid Solution for Intravenous (IV) or Intramuscular (IM) Administration

What is Ketamine HCl 500mg/10mL?

Ketamine HCl is a potent, rapid-acting dissociative anesthetic agent utilized extensively in controlled medical, surgical, and clinical research environments. Each 10 mL multiple-dose vial delivers a concentration of 50 mg/mL of ketamine base, engineered for precise titration.

Unlike conventional opioids, ketamine functions primarily as an NMDA (N-methyl-D-aspartate) receptor antagonist in the central nervous system. It induces a distinct state of sensory dissociation characterized by profound analgesia, amnesia, and sedation while generally preserving airway reflexes and cardiovascular stability.

Primary Indications & Clinical Applications

• Induction and Maintenance of Anesthesia: Utilized as a sole anesthetic agent for short diagnostic and surgical procedures that do not mandate skeletal muscle relaxation, or as an induction agent prior to the administration of other general anesthetics.

• Procedural Sedation & Analgesia: Frequently applied in outpatient surgical settings, emergency medicine, and specialized fields such as oral and maxillofacial surgery.

• Clinical & Research Protocols: Widely studied and implemented under strict clinical supervision for advanced neurological investigations and treatment-resistant mood disorders.

Dosage & Administration Guidelines

• Intravenous (IV) Route: For anesthesia induction, standard initial IV doses range from 1 mg/kg to 4.5 mg/kg, administered slowly over 60 seconds. An average dose of 2 mg/kg typically produces surgical anesthesia within 30 seconds, lasting approximately 5 to 10 minutes.

• Intramuscular (IM) Route: Initial IM doses generally range from 6.5 mg/kg to 13 mg/kg, yielding an onset within 3 to 4 minutes and a duration of 12 to 25 minutes.

• Titration: Dosage must be individualized and titrated carefully based on patient weight, age, clinical requirements, and concurrent medications.

Safety Information, Precautions & Boxed Warnings

CONTROLLED SUBSTANCE WARNING: Ketamine Hydrochloride is a Schedule III controlled substance with potential for misuse, abuse, and psychological dependence. Restricted to licensed medical facilities, surgical centers, and authorized professionals.

• Cardiovascular Effects: Ketamine can cause significant elevations in blood pressure and heart rate. It is contraindicated in patients for whom a sharp rise in blood pressure poses a severe medical hazard.

• Respiratory Monitoring: Rapid intravenous injection may lead to transient respiratory depression or apnea. Resuscitation equipment and personnel trained in airway management must be readily available during administration.

• Emergence Reactions: Patients recovering from ketamine may experience vivid dream-like states, confusion, hallucinations, or delirium. Premedication with a benzodiazepine is frequently utilized to mitigate these psychological side effects.

Storage and Handling

• Store at controlled room temperature between 20°C to 25°C (68°F to 77°F).

• Protect from light and store securely in compliance with federal and state regulations governing Schedule III controlled substances